SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2006-11-02
Filing Date Changed: 2006-11-27
Documents: 6
SEC Accession No.
0001193125-06-242048
Filing date: 2006-11-27
Accepted: 2006-11-27 16:10:23
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K d8k.htm 13631 FORM 8-K
2 EX-100.INS bmy-20060930.xml 50848 XBRL INSTANCE DOCUMENT
3 EX-100.SCH bmy-20060930.xsd 169604 XBRL TAXONOMY EXTENSION SCHEMA
4 EX-100.CAL bmy-20060930_cal.xml 859433 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
5 EX-100.LAB bmy-20060930_lab.xml 1060117 XBRL TAXONOMY EXTENSION LABEL LINKBASE
6 EX-100.PRE bmy-20060930_pre.xml 1389809 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
0001193125-06-242048.txt 3545804 Complete submission text file

Filer Information:

BRISTOL MYERS SQUIBB CO (Filer) (0000014272)
IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 061239595
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
345 PARK AVE
NEW YORK NY 10154
2125464000
 Mailing Address
345 PARK AVE
NEW YORK NY 10154